MARC Record from marc_columbia

LEADER: 05292fam a2200457 a 4500
001 4055329
005 20221027025255.0
008 960919s1997 nyua b 001 0 eng c
010 $a 96038941
020 $a0471140716 (alk. paper)
035 $a(OCoLC)35694486
035 $a(OCoLC)ocm35694486
035 $9AMM4221HS
035 $a(NNC)4055329
035 $a4055329
040 $aDNLM/DLC$cDLC$dDLC$dNNC-M$dOrLoB-B
050 00 $aQP801.P8$bP86 1997
060 10 $aQU 57 P985 1997
082 00 $a615/.7$221
245 00 $aPurinergic approaches in experimental therapeutics /$cedited by Kenneth A. Jacobson and Michael F. Jarvis.
260 $aNew York :$bWiley,$c1997.
300 $axiv, 581 pages :$billustrations ;$c25 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $gPt. I.$tHistorical Perspective.$g1.$tPurinergic Neurotransmission and Neuromodulation: A Historical Perspective /$rMichael Williams and Geoffrey Burnstock --$gPt. II.$tMolecular Pharmacology.$g2.$tAdenosine Receptor Subtypes: New Insights From Cloning and Functional Studies /$rGary L. Stiles.$g3.$tStructure, Pharmacological Selectivity, and Second Messenger Signaling Properties of G Protein - Coupled P2-Purinergic Receptors /$rTheresa M. Filtz, Kendall Harden and Robert A. Nicholas.$g4.$tRegulators of Endogenous Adenosine Levels as Therapeutic Agents /$rJonathan D. Geiger, Fiona E. Parkinson and Elizabeth A. Kowaluk.$g5.$tAllosteric Enhancement of Adenosine Receptors /$rJoel Linden --$gPt. III.$tMedicinal Chemistry.$g6.$tDevelopment of Selective Purinoceptor Agonists and Antagonists /$rKenneth A. Jacobson and A. Michiel van Rhee.$g7.$tModulators of Adenosine Uptake, Release, and Inactivation /$rAd P. IJzerman and Nora M. van der Wenden --$gPt. IV.$tTherapeutic Implications.
505 80 $g8.$tAdenosine, Ischemia, and Preconditioning /$rGuang-Shung Liu, James M. Downey and Michael V. Cohen.$g9.$tATP as a Cotransmitter With Noradrenaline in Sympathetic Nerves - A Target for Hypertensive Therapy? /$rCharles Kennedy, Gerald J. McLaren and Peter Sneddon.$g10.$tCardiac Eletrophysiology of Adenosine: Antiarrhythmic and Proarrhythmic Actions /$rLuiz Belardinelli, Anne B. Curtis and Barry Bertolet.$g11.$tThe Role of ADP in Thrombosis and the Therapeutic Potential of P[subscript 2T]-Receptor Antagonists as Novel Antithrombotic Agents /$rPaul Leff, Mark J. Robertson and Robert G. Humphries.$g12.$tRenal Action of Purines /$rEdwin K. Jackson.$g13.$tP[subscript 2] Purinoceptor Agonists: New Insulin Secretagogues Potentially Useful in the Treatment of Non-Insulin-Dependent Diabetes Mellitus /$rMarie-Madeleine Loubatieres-Mariani, Dominique Hillaire-Buys and Jeannie Chapal [et al.].$g14.$tPurinergic Modulation of Gastrointestinal Function /$rFedias L. Christofi and Michael A. Cook.
505 80 $g15.$tAdenosine Regulation of Neutrophil Function and Inhibition of Inflammation via Adenosine Receptors /$rBruce N. Cronstein.$g16.$tPurinergic Modulation of Septic Shock and Systemic Inflammation Response Syndrome /$rSanna Rosengren and Gary S. Firestein.$g17.$tThe Role of Adenosine in Asthma /$rMarlene A. Jacobson and Tony R. Bai.$g18.$tNucleotides and Nucleosides in Pulmonary Function /$rJeffrey S. Fedan.$g19.$tAdenosine Neuromodulation /$rThomas V. Dunwiddie and Bertil B. Fedholm.$g20.$tATP in Brain Function /$rMaria P. Abbracchio.$g21.$tPsychomotor Aspects of Adenosine Receptor Activation /$rMichael F. Jarvis.$g22.$tAdenosine and ATP in Epilepsy /$rLars J. S. Knutsen and Thomas F. Murray.$g23.$tAdenosine and Acute Treatment of Cerebral Ischemia and Stroke - "Put Out More Flags" /$rDag K. J. E. von Lubitz.$g24.$tPurines in Anesthesia /$rAtsuo F. Fukunaga.$g25.$tPurines and Nociception /$rJana Sawynok.$g26.$tAdenosine Effects in Sleep Apnea /$rDavid Carley and Miodrag Radulovacki.
505 80 $g27.$tThe Influence of Adenosine on the Developing Fetus /$rScott A. Rivkees.$g28.$tATP in the Treatment of Cancer /$rEliezer Rapaport.
520 $aThe only definitive book on the topic, Purinergic Approaches in Experimental Therapeutics covers all of the major therapeutic applications of purinergic receptors and reflects the very latest developments in this new area of therapeutic research.
520 8 $aTwenty-eight chapters, authored by an international group of contributors who are the leading authorities in the field, provide details on molecular pharmacology; medicinal chemistry; and therapeutic implications, including cardiology, metabolism, immunology, neurology, and cancer.
650 0 $aPurines$xReceptors$xAgonists.
650 0 $aPurines$xReceptors$xAntagonists.
650 0 $aAdenosine$xReceptors$xAgonists.
650 0 $aAdenosine$xReceptors$xAntagonists.
650 12 $aReceptors, Purinergic$xphysiology.$0https://id.nlm.nih.gov/mesh/D011983Q000502
650 12 $aAdenosine$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D000241Q000627
650 22 $aAdenine Nucleotides$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D000227Q000627
700 1 $aJacobson, Kenneth Alan,$d1953-$0http://id.loc.gov/authorities/names/n89640188
700 1 $aJarvis, Michael F.$0http://id.loc.gov/authorities/names/n96802819
852 00 $boff,hsl$hQP801.P8$iP86 1997